approves use of the pfizer-biontech vaccine. we will get the latest on the pharmaceuticals behind this. ♪ >> that will not be enough to offset the recession we have in 2020, but it is a step toward a brighter future. what will be important is that we can achieve recovery once the vaccine will have been deployed. oecd chiefwas the economist talking to bloomberg about the group's outlook, talking about a brighter future, a vaccine part of that. , hasnews this morning approved the pfizer-biontech vaccine, making britain the first western country to license a coronavirus vaccine. -- samet to sample deli for selling. different jurisdictions have different processes. there have been a lot of talk about getting things done as quickly as possible and as safely. why are we going to see different jurisdictions approving at different times? why does it work that way? >> good morning. obviously this is a matter of days we are talking, so today is the second of december, the usda is very likely to also approve the vaccine on the 10th of dece

the pfizer—biontech jab will be made available from next week.e'll start with the most elderly, and with people in care homes, and of course their carers, to make sure that others don't catch it. the uk expects to have millions of doses of the pfizer vaccine against covid—i9 available by the end of the year — and the first 800,000 coming next week. if you have any questions on the vaccine rollout or the tier system which comes into force into england today, you can get in touch with me @annitamcveigh or use the hashtag bbcyourquestions. england has returned to a tiered system of coronavirus restrictions, after the national lockdown ended at midnight. more than 55 million people are living in the strictest two tiers. non—essential shops in england are set to reopen today. businesses are hoping for a flood of customers to provide a much needed boost in the run up to christmas. people with relatives in care homes in england will be allowed to see them indoors from today. the government is distributing more than a million rapid tests so that families

the fda gives emergency authorization to the pfizer biontech coronavirus. we'll tell you what happens next. plus, the supreme court rejects a lawsuit backed by the president aimed at overturning the election results. is this the end of the road for mr. trump. >>> all hands on deck for georgia. both parties send in faces to support the vote. >>> live from cnn world headquarters in atlanta, i'm kim brunhuber, this is "cnn newsroom." >>> the first vaccinations are on the verge of becoming reality in the u.s. a snapshot of what the past 24 hours has brought shows why it's so desperately needed. the food and drug administration late friday gave emergency use authorization to the vaccine developed by pfizer and biontech. the head of the fda called it a significant milestone in battling the pandemic. injections can begin as soon as the u.s. centers for disease control and prevention gives its okay and that could happen later today. it follows with the u.s. breaking three records friday. hospitalizations hit more than 108,000 covid patients. the number of new confi

fred pleitgen is outside biontech headquarters in germany.s great news but a big new challenge. >> reporter: certainly is a big new challenge because of the logistical change. john, one of the things we keep talking about is the fact that the pfizer, biontech vaccine has to be stored and delivered around minus 100 degrees fahrenheit. that's a big logistical challenge. some doses handed out to americans originated not far from where i am in belgium and have been brought to kalamazoo, michigan, where they're being stored. there will be thousands of planes and trucks set in motion and logistics companies we talk to say it is a big challenge, but certainly something that they believe they can manage. we have also been speaking to the company, to biontech, the founder and ceo. he told me he believes the trial data they've gotten so far from the vaccine has been so good that they think they could get that emergency use authorization fairly quickly. you were saying possibly even today. they say they believe their vaccine will have a good profile. on

especially pfizer and biontech that needs to be stored at -80.istically, they are shipping and dry ice packages that keep it at temperature. it is in a vial that contains multiple doses. they all need to be administered and a certain amount of time. another important challenges organizing and finding the people that are going to be vaccinated first. the u.k. is lucky that it has a centralized health care system, so everyone is identifiable in that way. that will be key in distributing it. it is a huge logistical challenge. the storage conditions of the vaccine make it challenging, but some of the other candidates like moderna and the astrazeneca vaccine has easier storage solutions. but it will take a lot of coordination between the government and local gps. mohammed: of course, it is not just about getting vaccinated and distributing the vaccine. there's a large percentage of the population that needs to get vaccinated before you can start approaching herd immunity. how long do something like that take, and how much of the population needs to ge

fred pleitgen is live outside biontech's headquarters in germany. we're getting news this morning that packers apparently tried to access some of the detailed information about this vaccine. >> reporter: yeah, boris, and they actually did manage to access some of that detailed information. biontech put out a statement yesterday saying that during that hack that happened in the european medicine agency, also reviewing the trial data of biontech and pfizer to see if there's going to be an emergency use approval here in europe, system of that data was apparently accessed during that breach. biontech and pfizer say their data bases were not breached in all of this, and they don't have any indication that trial participant data had been in the handsov of hackers. this has been concerning for the company, and they have been straightforward about talking about. folks on the edge of their seats waiting for that committee meeting in the u.s. today. i spoke to the head of biontech a couple of days ago, and he was telling me he believes their trial data is so

has approved a pfizer-biontech vaccine to be used. let's get straight to sam fazeli, bloomberg intelligence's senior pharmaceutical analyst. sam, thank you, as always, for giving us a little part of your busy day. i know there are talks a vaccine would be available asap in the u.k., but does it mean that it will accelerate other jurisdictions, also saying they are ok with the vaccine being approved? sam: morning, francine. vaccinet news that the has been approved by the u.k. i do not think it will affect other jurisdictions. the fda already has its timeline set up for simmer 10 for the biontech meeting, and it is a public meeting, so anybody can listen to it and see all the data in its full glory, and of course december 17 for the motor in her vaccine, and we think -- moderna vaccine. this does not really impact much else. francine: sam, what does it impact? it will come a longer term, of course, impact lockdowns. how long will it take for, you know, lockdowns to easily fade? how much of a percentage of the population do you need to v

vaccine and it can the pfizer biontech vaccine and it ca n start the pfizer biontech vaccine and itore on that coming up, stay with us, in the meantime you can reach me on twitter. i'm @samanthatvnews thanks for watching. see you shortly. it was a drab start to monday, with a spell of wet weather gradually pushing steadily north and east. you move out of northern ireland this afternoon, and moving to scotland, where it will lingerfor afternoon, and moving to scotland, where it will linger for much of the day. behind a real cluster of shower sandwich to the south but the real contrast with the story today is the mild air pushing up from the south, in comparison to some cold air now just starting to nudge into the far north of scotland. the remainder of the afternoon sees that wet weather across the scottish borders into western scotland. behind, it stays overcast, drab and dreary with a scattering of sharp showers accompanied by some pretty brisk winds in the south but look at the temperatures, 13 to 15 degrees quite widely across england and wales. by contrast in scotland and northe

our top stories: the us regulator authorises the pfizer biontech coronavirus vaccine for emergency use. donald trump says the first person will be vaccinated in the next 2a hours. president trump's attempts to overturn the election result have potentially been dealt a final legal blow — the us supreme court rejects a lawsuit aimed at throwing out the votes in 4 states. borisjohnson and the eu say they're unlikely to strike a post—brexit trade deal by sunday — with differences over how a new relationship might look. plus: # all i want for christmas is you... a song released 26 years ago — and a christmas favourite — finally tops the charts here in the uk. the us food and drug administration has authorised the pfizer—biontech coronavirus vaccine for emergency use. the agency had come under intense pressure from the trump administration to approve the vaccine‘s use. president trump has released a video on twitter to explain what happens next. through operation warp speed my administration provided a total of $14 billion to accelerate vaccine development and to manufacture all of the top c

biontech will be the marketing authorisation holder for the biontech will be the marketing authorisationwe called our development programme for covid—19 lightspeed because you cannot go faster than light and this is what we aimed for. this journey started in january this year and was devoted to the development of a well tolerated and effective covid—19 vaccine following the highest scientific and ethical standards. this was a journey of 10-11 standards. this was a journey of 10—11 months which started with engineering multiple vaccine candidates of which several entered clinical testing phase one and april this year. injuly we clinical testing phase one and april this year. in july we selected together with our partner pfizer one of those candidates the most promising one for a large phase three trial and in november this year we reported that in this trial vaccine has made all primary efficacy points. 0n the next slide you can see that project lightspeed has in fact global concerted large—scale effort. 0ur phase three trial has been conducted in multiple countries in the us, argentina,

britain's regulator reacted to the news, flagged up the incidents to pfizer and biontech. they said they're going to launch an investigation into why this occurred and in the meanwhile as a precautionary measure, they have called on anyone who has a reaction or history of reactions to not take the vaccine. they have described this as a precautionary measure. we have heard from pfizer and biontech who say they are supporting the investigation by the british regulator, and support this precautionary measure. it's important to look at the bigger pictures. two health care workers, a hiccup, not life threatening . t clinical trials are not going to reveal everything. it included 40,000 people. when you roll out to the larger population, it's millions. where occurrences will finally come up when you start rolling this out. it's all part of the uk to be the first western country to roll out the vaccine. again, let's look at the larger picture here. first western country to approve the vaccine, lots of hope around a vaccine that is 95% effective. right now, they are vaccinated the

have approved the shot made by pfizer and beyond tech. -- and biontech. of the vaccine are ready from belgium. in the u.s., an fda panel will meet next week to discuss the vaccine. global news 24 hours a day, on air and on quicktake by bloomberg, powered by more than 2700 journalists and analysts in over 120 countries. am ritika gupta. this is bloomberg. alix: thank you so much. up orard guy round european markets are closing. let's get a quick check of where u.s. markets are. you have the reflation remix continuing. you do not have the rally we saw in equities. the weaker dollar story continuing to permeate, the dollar did get a bid earlier. they were able to move on that and now you have the euro-dollar up 1.20. that was the highest level since 2018. i want to bring your attention to what is happening with yields . a bought us in bond yields -- a modest move in bond yields. the curve is steeper. what is important for the market, particular when it comes to real yields come are the breakevens continuing to rise. 1.80 five for the 10 year breakeven. as lo

brittain is using the pfizer biontech vaccine and that will continue as well. this news comes from the u.k. as experts in the united states warn america's vaccine rollout isn't moving quickly enough. i spoke earlier with cnn medical analyst about the concerns here in the united states. >> you are a public health professional. this is something i know shakes you to your core when you see that vaccines are not being rolled out here in the united states at the pace at which they need to be rolled out. and i've been really interested to hear from you because you're not trying to blame people or point fingers, you're saying, we need to see what's wrong and fix it. >> that's right. this is not about blame. this is about introspection and having the humility to say this is the most ambitious vaccine plan we have ever undertaken in the way. let's not overpromise and under deliver. let's figure out what went wrong. if the initial expectation was 40 million people or 40 million doses distributed by the end of the year and we've only been able to administer 2 doses, what

the fire and biontech vaccine candidate asked the pfizer and biontech candidate -- the pfizer and biontech vaccine candidate is not one step closer to approval in the u.s. deeper with our guest. what was your biggest take away from the fda report this morning? guest: first, it is very thorough and transparent. it is great to see all of this data out for the public. that is very different than what occurred in the u.k.. the second is that it looks excellent. 95% is certainly confirmed. the safety looks really solid. the oldest person to receive the vaccine was 89. interesting that the first person to receive it in the u.k. today is 90. but everything looks really good, and of course, that is going to be the subject of a whole day of discussion, to rake it over and ask questions on thursday, so it is very encouraging. guy: here in london, we are already starting to vaccinate people. do you think the u.k. was right to get a move on? do you think the u.k. was right to go early? : well, if you want to win the race to get the first open use of the vaccine, yes, but i do think, especially in the

eu member states preparing to roll out the pfizer-biontech vaccine after it was given the green lighttors. france, italy, and germany say they will begin max fascinations by sunday.

mr babis received the pfizer—biontech vaccine at prague's central military hospital.ld be vaccinated as he had his spleen removed as a teenager. he also walked back on an earlier claim that he would personally oversee the vaccination programme, after his former health minister turned down the role. the plan is to inoculate around 70% of the population. in the italian capital rome, health workers received their first doses of the pfizer—biontech vaccine. a medical officer and a senior professor were among the first three to get the jab at italy's national institute of infectious diseases. italy was the first western country hit by the virus and has reported more than 70,000 deaths since its outbreak in february. it has highest death toll in europe and the fifth—highest in the world. 0ur europe correspondent damien mcguinness has been telling us about the vaccine rollout in germany. yes, that's right, so i'm actually at a former airport, this closed down a few months ago. it is now being used as one of the many mass vaccination centres set up across germany — 400 in tot

pharmaceutical giant pfizer and its german partner biontech.he fda is expected to make its decision on approval based on the outcome of the meeting. new york governor andrew cuomo told reporters on wednesday, if approved, vaccines could arrive in the state as early as this weekend. he said the first batch of 170,000 doses will be sent to medical institutions via 90 delivery bases equipped with freezers. they will be given to health care workers and others. meanwhile, the u.s. defense department says it's prepared to start swiftly administering vaccines to military personnel and others once emergency use authorization has been issued. officials said wednesday they expect to receive around 44,000 doses as early as next week. they said the batch will be distributed to 16 locations. they also said the sites have been chosen because they have sufficient medical staff and cold storage capabilities. three of the sites are outside the united states. officials named cadena air base in japan and facilities in south korea and germany. in britain, inoculat

vaccinations will begin across the european union next week, after its regulater approves the pfizer/biontechaccine. two men are found guilty of the manslaughter of 39 migrants found dead in the back of a lorry in essex last year. hello and welcome if you're watching in the uk or around the world — and stay with us for the latest news and analysis from here and across the globe. european officials are meeting right now in brussels to stop the spread — from britain — of a new, more contagious, form of covid—19. france is enforcing a 48—hour blockade of passengers and goods. that's caused long tailbacks of lorries in southeast england. many other countries have suspended flights. more than 30 countries have now banned flights from the united kingdom — the number's been constantly rising. in the last few hours, spain, india, hong kong, swizerland and russia have all suspended flights from the uk. overall, across europe, 16 countries have imposed restrictions, including ireland, germany, france, and belgium. today, eu ambassadors are holding emergency talks to agree a common strategy. and british

we held a public advisory committee on thursday about the pfizer biontech application. the advisory committee consists of experts who reviewed clinical data from pfizer and biontech submissions and provided their own recommendations related to the data concerning the safety and effectiveness of the product. agreed that the vaccine's benefits outweigh its risks. we have also made clear through two guidance documents, the information a developer should provide to us for their covid-19 vaccine, helping americans understand what data we would be looking at during our review process. yesterday, we have posted important information to help health care providers understand the benefits, risks, and proper use of this vaccine, including fact sheets for health care providers and vaccine recipients. instructions for use, the letter of authorization to the requester, which spelled out the conditions under which use of the product is authorized. we also intended to post the decision memorandum, which outlines the basis of our decision. all of this information helps the public unders

that's what pfizer and biontech tell us. a little plaster on the other side of his left arm. who actually did the clinical work, just amazing. and i wish we had time to take you through the whole hospital to see how busy and incredible you all are. we owe you big. we really do. one of the things is that i think the administration deserve some credit, getting us off the ground, i also think that it's worth saying that this is a great hope, i'm doing this to demonstrate that people should be prepared, when it's available, to ta ke prepared, when it's available, to take the vaccine. there is nothing to worry about. i'm looking forward to worry about. i'm looking forward to the second shot, so is jail. she had her shot earlier today. she loves shots, i know. —— so isjill. but the important thing is that it's worth stating that this is just the beginning. it's one thing to get the vaccine out and now that we have done it, it's going to be on the road as well. but it's going to take time. it's going to take time. in the meantime, i hope people listen to all the experts and the doct

. —— biontech. as it gears up to get the go-ahead. -- biontech.ill be guided through a 1—way system, centres a re be guided through a 1—way system, centres are ready, now we're just waiting for the vaccine. a cash injection in the us. republicans and democrats and months of wrangling to agree on a $900 billion financial relief package. after a long and arduous year, after a year full of bad news, finally, we have some good news to deliver to the american people. can brexit negotiators net a free trade deal? eu access to the uk's fishing waters are still said to be stalling negotiations. hello and welcome. european nations have begun to apply travel bans with the uk after it reported a more infectious and "out of co ntrol" coronavirus variant. denmark, italy, and the netherlands have already detected the new strain. eu ambassadors are to meet for emergency talks later to work out a common strategy. france has banned arrivals from the uk by most routes, and including freight. other countries include ireland, italy, the netherlands, belgium, and germ

the first batch of the pfizer—biontech jabs arrived here from belgium yesterday. roll—out is a logistical challenge — with the firstjabs expected to be given on tuesday. here's our health correspondent katharine da costa. the nhs is gearing up for the biggest vaccination programme in its history. 50 hospital hubs are set to receive the first batches of the pfizer—biontech vaccine. huge efforts are under way to prioritise patients over 80, invite care home staff into hospitals, and it's likely some nhs staff will be among the first to be vaccinated, so that doses are not wasted. the difficulty lies with the ultra—low temperature needed to store and transport this particular vaccine. it comes in boxes of nearly 1,000 doses, packed in dry ice. brussels airport has been ramping up preparations, with up to 50% of vaccines expected to be transported by plane. think of a large pizza box, that's the way we are describing it. that's got to be stored in a fridge at —70. to be frank, the only way you can really do that at the moment is to store them inside nhs hospital hubs.

. >>> just ahead on the program, one step closer, a key panel recommends authorizing the pfizer biontech coronavirus vaccine for emergency use in the u.s. we'll explain what happens next. >>> also. >> probably for the next 60 to 90 days we're going to have more deaths per day than we had in 9/11. >> that dire warning from the head of the centers for disease control. why medical experts say a vaccine won't come fast enough to stave off a grim winter. >>> plus, keeping up the fight. president trump takes his battle to overturn the election results to the country's highest court. welcome, everyone, if all goes well, the first doses of the pfizer biontech covid vaccine could be reaching american communities within days. it is now up to the u.s. food and drug administration whether to accept its own advisory board's recommendation to authorize emergency use. america's top infectious disease doctor says it was the fda's panel decision on thursday that finally got the ball rolling. >> the reason i think this is so important is that we want to make sure that we impress the american public that d

emily: that was sean marett, biontech's chief commercial officer.t for this edition of "bloomberg technology." i am emily chang in san francisco. this is bloomberg. ♪ ♪ haidi: a very good morning in sydney. asia'scounting down to major market opens. shery: i'm shery ahn in new york. welcome to "daybreak asia." stoxx touch records for second day amid optimism on the stimulus. investors also welcome positive

the eu's medical regulator has approved the use of the pfizer—biontech vaccine, the first coronavirusdicines agency said it had demonstrated an efficacy of 95%, and could be used in people aged 16 and over. with me is our news reporter mark lobel. tell us more on this. there is some difference in the timings are. quite a bit, despite the fa ct are. quite a bit, despite the fact that britain and america and canada had approved the pfizer biontech vaccine earlier this month, the european medicines agency, which is instructed by the eu to look at proving their vaccines for them, took a much more careful approach, looking at more evidence, putting in more checks as they thought it was more appropriate for a max vaccination campaign for its 446 million people, so they did not go down the emergency route that america and pretended but down the similar routes to switzerland with more checks, but the tipping point came when eu leaders told them to hurry up, they saw 300,000 europeans dying and saw what was going on elsewhere and so, this resulted in the ema coming out a day sooner with their

the pfizer biontech, dr. wen, is the first out of the gate. the second by drug maker moderna, that could be authorized later this coming week. that's a significant development as well. but in a new op ed that you wrote for the washington post, you say you have two major concerns about these vaccines, side effects and coincidence. explain what you mean. >> we need to be anticipating what are the scenarios that could really derail the acceptance of the vaccine. here are two. one is that there are side effects. they are normal. they are expected and actually they mean that the vaccine is working, our body is producing the appropriate immune response. that includes pain, redness, swelling at the injection site. people may experience fatigue, body aches, fever, headache. these, again, are normal. if people are not expecting it, then it could lead to people not getting the second dose because this is a two dose vaccine or to misinformation. that transparency is important. in addition, we note that one of the two priority groups going to get the vacc

the pfizer-biontech covid-19 receivedthe pfizer-biontech covid-19 vaccine earlier this month.t, how president trump has raised over 500 million dollars since october as he tries to overturn the election. how much of that money is going into his own pockets? stay with us. ♪ [music break] amy: "memories of the future" by meklit featuring preservation hall horns. this is democracy now!, democracynow.org, the quarantine report. i'm amy goodman with juan gonzalez. as president trump continues to look for ways to overturn the 2020 election, he has also continued to raise massive sums of money -- including $250 million since election day. trump's largest single days for online donations actually came after election day. on november 6, he raised nearly $750,000 per hour. "the new york times" reports that more than $60 million of the money he has raised has gone to a new political action committee that trump will control after he leaves office. for a sense of scale, this is about as much money as trump spent to win the presidential -- republican presidential nomination in 2016. "the ti

moderna has joined biontech and pfizer in approval of its vaccine.thers are in advanced stages of development. in russia, the controversial sputnik5 vaccine was approved in august in china is allowing vaccinations without regulatory approval. biontech-pfizer's vaccine purports to offer 95% protection against covid-19, but it has to be transported in extremely cold temperatures, posing a major hurdle for its distribution. brent: i'm joined by an associate fellow with the global health program in the u.k.. it's good to have you on the program. the u.k. will start next week with mass vaccinations. would you say this is the turning point in this pandemic? david: this is a fantastic day, to know that we have got a vaccine that has gone through rigorous scrutiny and has come through, knowing that is going to be effective, knowing that it's going to be safe. that is the first hurdle. the next is to make sure that we get it into enough people to protect those who are at greatest risk. after we've protected those at risk, the next hurdle is going to be to rol

we are going to stay with the broader coronavirus theme and speak to sean marett of biontech . approved for use in europe. there is a lot to get to. we will try to get to all of it. that's next. this is bloomberg. ♪ ♪ watchingou are "bloomberg surveillance." i am yousef gamal el-din in dubai. let's get you the bloomberg business flash stories. tesla was the biggest drag on the s&p 500 on its first day of trading on the benchmark. the electric car maker now represents 1.6% of the index, ending the day as its sixth heaviest weighted stock. the fall follows a surge on friday, when index fund managers purchased tens of millions of shares ahead of inclusion. platonic -- peloton is purchasing a rival. sales have a short sword this year -- sales have soared this year but the company has struggled to keep up with demand. vodafone is offering to buy out the remaining shareholders in german telecom firm kdg. it comes seven years after it originally agreed to buy the company. back then, it acquired about 77% but was blocked from buying the the rest, including elliott management, who wante

we've had lots of questions about what today's approval of the pfizer/biontech vaccine means. vaccine. russia and china have approved the vaccine of their own but the uk is the first to approve the pfizer and biontech vaccine and that is down to the speed of the uk regulator the mhra which started work injanuary and has been working round the clock since then going through thousands of pages of data and trying to see if it means the efficacy and safety standards. the ear made the body which regulates the vaccine for the eu has questioned the speed this has happened but the head of the mhra said this morning that no corners have been cut. david asks why are those classed as extremely vulnerable and over 65 is so low on the list? this refers to the maxim priority list which has been drawn up priority list which has been drawn up by priority list which has been drawn up by the joint priority list which has been drawn up by thejoint committee on vaccination and immunisation is and they cah is the biggest risk factor so what they want is the older age groups to be right at the fron

uk is the first in the world to approve pfizer and biontech's covid-19 vaccine with rollout as earlys this coming monday. back here in the state, some head winds remain not just for our own vaccine approval, but how states will pay for it all ylan mui is joining us >> now that the vaccine is finally almost here, states say they need federal funding to follow and fast. for months they have been warning that they need more financial help from washington in order to take on this unprecedented public health campaign and the estimated cost is $8.4 billion. health officials say that will help with things like buying august the supal the super cold freezers they need to store it, and they have to build up a technology to track everyone who has already gotten a shot and make sure that they come back for a second one. and they also have to market the vaccine to people who are eligible and reach out to those who are sceptical. but they say the biggest costs are hiring and training enough vo workers to administer the vaccine. >> unless we can figure out a way to get it into people's arms, it is

approving the pfizer/biontech vaccine for use. it should be available across the u.k. starting next week, with priority going to care homes, frontline workers, and the elderly. joining us with more from berlin is bloomberg's european health care reporter. naomi, it is approved. what does the rollout actually look like? is the infrastructure in place to distribute this quickly? reporter: good morning. this is approved. the rollout will probably be a matter of months, not days or weeks. the government has said they have set up 50 hospitals to deliver this vaccine. it will also in some cases be able to be put into a cooling carrier to be brought directly to care homes and given to people there. this is not a case of snapping the fingers, and next week suddenly 20 million people in the u.k. have been vaccinated. guy: how far behind as the rest of europe? naomi: that is a very good question. the rest of europe is probably a few weeks behind. we will have to see how the review shakes up in europe. there has been a rolling review in europe that started in october. the documen

a panel of american experts have voted to recommend emergency approval of the pfizer/biontech coronavirus vaccine in the united states. a stark warning from britain's prime minister — the uk should prepare itself for no post—brexit trade deal with the eu. borisjohnson says there was now a strong possibility that talks would fail. i stand ready to talk to anybody, our friends and partners in the eu whenever they want. at the moment i have to tell you, in all candour, the treaty is not there yet. and hollywood star viola davis tells us about her new role as the pioneering blues singer, ma rainey. hello and welcome if you're watching in the uk or around the world. i'm kasia madera, stay with us for the latest news and analysis. in the last few minutes, a top us government advisory panel has recommended for authorisation the country's first vaccine against covid—19. the committee agreed 17 to four that the known benefits of the vaccine, developed by pfizer and germany's biontech, outweigh the risks in adults over 16 years of age. the formal approval from the food and drug administration is ex

what is your reaction to the ema's approval to the pfizer biontech vaccine?rson but i'm the spokes person of the biggest political group in the european parliament. i am political group in the european parliament. iam happy political group in the european parliament. i am happy that we have this recommendation now, and along the circumstances, the european commission would have 67 days to make formal approval. i am sure that it will take less than six hours, so that we have a formal conditional market approval today and we will start the vaccination in germany on the 27th. and i think that all the eu countries will start that same day. i think it is a good thing. we have more safety then with the emergency approval, and still we have a lot of vaccine available. no country in the world will have enough for the next two or three months, but the share of the european reserve did not go to the us or the european reserve did not go to the us orthe uk, european reserve did not go to the us or the uk, so we will have many people vaccinated in the next weeks. are you

millions of doses of the pfizer—biontech vaccine will arrive in the next few days.he prime minister and his top medical advisers warned it would still take months to get the jab to everyone who wanted it and strict rules needed to stay in place. our medical editor fergus walsh reports. this is an historic moment. at last, there is a clear path out of this pandemic, thanks to vaccination. the uk is the first country in the world to approve the pfizer/biontech vaccine, seen here on the production line in belgium. the prime minister made clear the vaccine won't change life for now, but hope is on the horizon. prime minister, now we have a vaccine, how important is this moment? when you consider the damage that, as i was saying earlier, the damage that this virus has done to human life across the planet, the economic damage, the social damage, to say nothing of the cost in life and suffering, it is a fantastic moment. more than 20,000 volunteers got two doses of the vaccine as part of the trials. it proved 95% effective at preventing covid, even among those in their 70s

millions of doses of the pfizer—biontech vaccine will arrive in the next few days. the prime minister and his top medical advisers warned it would still take months to get the jab to everyone who wanted it and strict rules needed to stay in place. our medical editor fergus walsh reports. this is an historic moment. at last, there is a clear path out of this pandemic, thanks to vaccination. the uk is the first country in the world to approve the pfizer/biontech vaccine, seen here on the production line in belgium. the prime minister made clear the vaccine won't change life for now, but hope is on the horizon. prime minister, now we have a vaccine, how important is this moment? when you consider the damage that, as i was saying earlier, the damage that this virus has done to human life across the planet, the economic damage, the social damage, to say nothing of the cost in life and suffering, it is a fantastic moment. more than 20,000 volunteers got two doses of the vaccine as part of the trials. it proved 95% effective at preventing covid, even among those in their 7

a panel of experts vote to recommend emergency approval of the pfizer/biontech coronavirus vaccine in the united states — a final verdict could take days. a stark warning from britain's prime minister — borisjohnson, says there's a ‘strong possibility‘ that the uk will fail to strike a post—brexit trade deal, with the european union. i stand ready to talk to anybody, our friends and partners in the eu, whenever they want. at the moment i have to tell you, in all candour, the treaty‘s not there yet. pushing the poorest further into poverty — how coronavirus is hitting those already struggling — and making a hard situation even worse. and — hollywood star viola davis tells us about her new role as the pioneering blues singer, ma rainey. let's start with the news that broke in the last hour — a panel of experts in the us has endorsed the pfizer biontech coronavirus vaccine for emergency use. it paves the way for approval by the us food and drug administration. pfizer says its vaccine has an efficacy rate of 95%. other countries, including britain and canada, have already given the vaccin

emily: that was sean marett, biontech's chief commercial officer. it for this edition of "bloomberg technology." i am emily chang in san francisco. this is bloomberg. ♪ it's moving day. and while her friends are doing the heavy lifting, jess is busy moving her xfinity internet and tv services. it only takes about a minute. wait, a minute? but what have you been doing for the last two hours? delegating? oh, good one. move your xfinity services without breaking a sweat. now that's simple, easy, awesome. xfinity makes moving easy. go online to transfer your services in about a minute. get started today. i hope my insurance pays for it. can you tell me how much this will be? - [cashier] 67. - sorry. - wait, have you heard about goodrx? goodrx finds free coupons to help you save up to 80% on your prescriptions. - wow, i had no idea. - [announcer] goodrx, stop paying too much for your prescriptions. >> the opinions and views expressed do not reflect those of bloomberg lp or its employees. paid program.ing as a young country, the united states needed to as

biontech says it is confident that is widely approved vaccine will work against the new strain of the virus in britain. >> the vaccine is about to be rolled out across the european union. but the rapid spread of a new variant of the coronavirus in britain has sparked concerns. biontechand phizer researchers say that they are confident there virus will work against these new strains. >> this means that 99% of it is still the same. we know the new response induced by our vaccine is a -- attacking this protein on multiple sides. >> so far, there have not been any major problems with inoculations already being administered in britain, canada and the u.s., article workers have reported relatively few side effects. following the eu approval of the biontech phizer vaccine, many citizens are eager to be vaccinated. >> we will be able to reach sufficient vaccine doses and immunity rate in the range of 60 to 70%. that could help us to control the pandemic before next week. >> biontech is already planning on expanding production capacity. vaccine for all of europe is only manufactured at thpfize

the rollout of the pfizer biontech covid vaccine begins for millions of people across the eu — startingaly and the czech republic. storm bella brings gusts of more than a hundred miles an hour — with roads in parts of wales, and devon and cornwall blocked by falling trees. and after 80 years as the village postmistress in shropshire, from world war two to the transformation of the postal service — postmistress kay white finally retires after after 80 years working in the same post office in shropshire. hello and welcome if you're watching in the uk or around the world. borisjohnson has promised that "big" changes are on the way for the uk following his brexit deal with the european union. in an interview with the sunday telegraph, he said he wants to focus on "leveling up the country" and "spreading opportunity" across the uk. mrjohnson said the brexit deal would provide new regulatory freedoms to "deliver for people who felt left behind". but some fishing leaders have accused him of "caving in" to the eu and sacrificing their interests. mps will vote on the deal in parliament on 30 dec

such as gelitin and latex. >> canada approved the pfizer and biontech vaccine there and citizens can start receiving shots next week. >> dr. fauci said there are five other vaccines in the pipeline. moderna may come out next month and johnson and johnson and others may be early next year. >> all right. debra alfarone in washington. stephen hahn talks about the green light of the first vaccine in the u.s. >> americans will have to wait even longer for another round of coronavirus aid. lawmakers just passed a one week extension of government funding to buy more time to come up with a deal. top democrats rejected a $916 billion offer from treasury secretary mnuchin. they refused the stimulus checks and they want more help for americans when it comes to federal unemployment benefits. >> facebook is being hit with a landmark lawsuit. trade commission accuse he the social network giant of being an illegal monopoly. diane king hall is in new york. what does this mean and what effect could this have on their operation? >> they could be required to divest assets including whatsapp and instgra

here's damian mcguiness on biontech, and the couple who founded it. founded by a german turkish couple, professor sahin — who came to germany when he was four with his father who came to work and a german carfactory here. in a german car factory here. he later became a doctor, became a very famous cancer researcher. and was responsible for some quite round breaking technology. he then set up with his wife, who is also a researcher and scientist, also very renowned in herfield, the company biontech, only in 2008. now, they originally were focusing on some quite cutting edge cancer research. they then segued at the beginning of this year to trying to find a vaccine using similar technology. professor sahin says that as soon as he read about what was happening in china, in wuhan, right at the big about what was happening in china, in wuhan, right at the beginning of the pandemic, he read about it in the lancet, and he says that straightaway, he took all the resources of biontech , which are relatively small pharma start up to put it right into creating a

the ceo of biontech is testing their vaccine against the new variant.e's scientifically confident that a vaccine will still be effective. he says essentially that the vaccine or that the virus, the new mutation of the virus has nine mutations but the vaccine attacks the virus in so many different ways, they still believe that the vaccine will be just as effective as before. however, he also did say, this is very important, he said that if the virus itself becomes more effective at infecting people, which of course the u.k. believes could be the case, then it could actually take longer to achieve herd immunity in any country. let's listen in to what he had to say. >> the topic of herd immunity, there's always this discussion about 60 to 70%, but if the virus becomes more efficient in infecting people, we might need even a higher vaccination rate to ensure that normal life can continue without interruption. >> so that was the ceo of biontech, and he said also, lawy laura, there had been mutations in the past. and they said in pretty much all cases up unti

that will be on par with the pfizer biontech vaccine. we'll hear more from the scientists and researchers. and it mimics the immune system in a better way. they're touting that winning formula. advertising that as a way to bring the efficacy up. bring it on par with pfizer and biontech and advertising this is cheaper, most importantly, it's easy to transport. isa? >> selma, thank you for that breaking news. >>> the last hour heard from health secretary matt hancock. they say this clears the path of the pandemic by spring. one view rrologist said that's t optimistic. >>> stay with cnn as we continue to follow the breaking news. >>> plus, more on the devastating earthquake rocking croatia. the surge for survivors continue. >>> plus, millions of americans plan to welcome in the new year as two nations sweep the nation. have a check on your forecast next. finish quantum with activeblu technology, cleans withoutut pre-rinsing. switch to finish and skip the rinse to save water. robinwithout the commission fees. so, you can start investing toda